RIPK3 and colitis: VDR inhibits necroptotic apoptosis, alleviates inflammation, and suppresses the induction of colitis by preventing receptor interacting serine/threonine kinase 3 (RIPK3) from binding to RIPK1 (Shi et al., 2020).